{
    "Trade/Device Name(s)": [
        "STA\u00ae Cephascreen Kit",
        "STA\u00ae Cephascreen"
    ],
    "Submitter Information": "Diagnostica Stago, Inc.",
    "510(k) Number": "K053111",
    "Predicate Device Reference 510(k) Number(s)": [
        "K792048"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GFO"
    ],
    "Summary Letter Date": "01 May 2006",
    "Summary Letter Received Date": "02 May 2006",
    "Submission Date": "November 1, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7925"
    ],
    "Regulation Name(s)": [
        "Partial Thromboplastin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Activated partial thromboplastin time (APTT)",
        "Factors XII",
        "XI",
        "IX",
        "VIII",
        "X",
        "V",
        "II",
        "Fibrinogen",
        "HMW kininogen (Fitzgerald factor)"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "STA line analyzers",
        "STA Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Coagulation assay",
        "Recalcification in presence of cephalin and factor XII activator"
    ],
    "Methodologies": [
        "Screening test for intrinsic and common coagulation pathways"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for STA\u00ae Cephascreen Kit for determination of activated partial thromboplastin time (APTT) using coagulation assay on STA analyzers",
    "Indications for Use Summary": "Provides reagents for the determination of activated partial thromboplastin time (APTT) in citrated plasma on the STA line of analyzers",
    "fda_folder": "Hematology"
}